In a head-to-head study, three continuous glucose monitoring systems showed different measurements in the same person, which ...

Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by ...

Medtronic has submitted 510(k) applications to the U.S. Food and Drug Administration seeking clearance for an interoperable pump.

Whichever category you fall into, you can take appropriate steps to control your glucose levels before ... they may also want to monitor your kidney function after the procedure to determine when you ...

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

Afon Technology has been a leader in diabetes innovation with its GlucowearTM device, the world’s first non-invasive glucose sensor ...

What factors are influencing the growth of the Blood Glucose Monitoring Device Market over the forecast period? What is the competitive landscape in Vietnam Blood Glucose Monitoring Device Market?

Algorithm transfer is a key prerequisite for the development of a commercial wearable non-invasive glucose monitor for universal use Study based on the participation of 50 people with type 2 ...

The U.S. Food and Drug Administration approved DexCom, Inc.’s (NASDAQ:DXCM) Dexcom G7 15-Day Continuous Glucose Monitoring System for people over 18 with diabetes. With an overall Mean Absolute ...

New features include Apple Watch connectivity, medication logging, and customizable alerts for better glucose tracking. Markets are messy—but the right setups can still deliver triple-digit gains.

DexCom shares rose in premarket trading Thursday morning after the company said it received regulatory clearance in the U.S. for its diabetes monitoring system. Shares traded 8.5% higher at $72.55.